Document:

Exhibit 10.5

 

THE SECURITIES DESCRIBED HEREIN HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933 OR THE SECURITIES LAWS OF ANY STATE OR ANY OTHER JURISDICTION. THERE ARE FURTHER RESTRICTIONS ON THE TRANSFERABILITY
OF THE SECURITIES DESCRIBED HEREIN.

 

THE PURCHASE OF THE SECURITIES INVOLVES A HIGH DEGREE OF RISK AND
SHOULD BE CONSIDERED ONLY BY PERSONS WHO CAN BEAR THE RISK OF THE LOSS OF THEIR ENTIRE INVESTMENT.

 

SUBSCRIPTION AGREEMENT

 

This Subscription Agreement (this “Agreement”)
is entered into as of [_], 2021 between Lakeshore Acquisition II Corp., a Cayman Islands exempted company (the “Company”),
RedOne Investment Limited, a British Virgin Islands company (the “Sponsor”) and [Investor] (the “Purchaser”).

 

RECITALS

 

WHEREAS, the Company was incorporated for the purpose
of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination
with one or more businesses (a “Business Combination”);

 

WHEREAS, the Company has confidentially submitted
to the U.S. Securities and Exchange Commission (the “SEC”) a draft registration statement on Form S-1 (the “Registration
Statement”) for its initial public offering (“IPO”) of units (the “Public Units”), at
a price of $10.00 per Public Unit, each Public Unit comprised of ordinary share, par value $0.0001 per share (“Ordinary Shares”,
and the Ordinary Shares included in the Public Units, the “Public Shares”), one right to receive one-tenth of one Ordinary
Share automatically upon the consummation of the Company’s initial business combination (“Rights”, and the Rights
included in the Public Units, the “Public Rights”), and one-half of one redeemable warrant, where each whole warrant
is initially exercisable to purchase one share of Ordinary Shares at an exercise price of $11.50 per share, subject to adjustment (the
 “Warrants”, and the Warrants included in the Public Units, the “Public Warrants”);

 

WHEREAS, proceeds from the IPO and the sale of
the Private Placement Units (as defined below) in an aggregate amount equal to the aggregate gross proceeds from the IPO will be deposited
into a trust account for the benefit of the holders of the Public Shares (the “Trust Account”), as described in the
Registration Statement;

 

WHEREAS, following the closing of the IPO (the
 “IPO Closing”), the Company will seek to identify and consummate a Business Combination;

 

WHEREAS, in connection with the IPO, the Sponsor
and the Purchaser will purchase, in a private placement that will close simultaneously with the IPO Closing, units which are identical
to the Public Units except that the Warrants underlying such units will be non-redeemable and exercisable on a cashless basis so long
as they are held by the Sponsor, the Purchaser or their respective permitted transferees (the “Private Placement Units”),
for a purchase price of $10.00 per Private Placement Unit;

 

WHEREAS, the parties wish to enter into this Agreement,
pursuant to which the Purchaser shall subscribe for and purchase (i) a portion of the total number of shares of Ordinary Shares to
be issued prior to the IPO (“Founder Shares”) and (ii) Private Placement Units (together with the Founder Shares,
the “Subscribed Securities”); and

 

WHEREAS, the Company and the Sponsor have entered
into or intend to enter into agreements (collectively, the “Subscription Agreements” in the form of this Agreement
with certain affiliates of the Purchaser (together with the Purchaser, the “Subscribing Parties”) for the purchase
of Founder Shares and Private Placement Units set forth therein.

 

     

     

    

 

WHEREAS, the Company, the Sponsor and the Subscribing
Parties intend for the purchase of Founder Shares and Private Placement Units as set forth herein to be made pursuant to Rule 506(c) of
Regulation D promulgated under the Securities Act.

 

NOW, THEREFORE, in consideration of the premises,
representations, warranties and the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt,
sufficiency and adequacy of which are hereby acknowledged, the parties hereto agree as follows:

 

AGREEMENT

 

	 	1.	Sale and Purchase.

 

	 	(a)	Securities.

 

(i)  Subject to the terms and conditions
hereof, the Purchaser hereby irrevocably subscribes for and agrees to purchase from the Company, and the Company agrees to issue and sell
to the Purchaser, the number of Subscribed Securities set forth on Schedule A hereto for the aggregate purchase price
set forth on Schedule A hereto (the “Initial Purchase Price”). The Purchaser acknowledges that the
Subscribed Securities, and any securities of the Company that may be distributed to the Purchaser on account of the Subscribed Securities
(collectively, the “Securities”), will be subject to restrictions on transfer as set forth in this Agreement.

 

(ii) On the date hereof, (A) the Company
shall issue to the Purchaser the number of Founder Shares set forth on Schedule A hereto, in consideration for the Purchaser’s
payment of the portion of the Initial Purchase Price applicable to such Founder Shares, as set forth on Schedule A hereto,
by wire transfer of immediately available funds or other means approved by the Company, and (B) the Sponsor shall forfeit to the
Company for cancellation, for no consideration, and have no further right, title or interest in, an equal number of Founder Shares. If
the IPO Closing has not occurred by [December 31, 2021], then the Company will promptly redeem the Purchaser’s Founder Shares
issued pursuant to this Section 1(a)(ii) for a cash payment equal to the Initial Purchase Price paid by the Purchaser in respect
of such Founder Shares, and this Agreement shall terminate and be of no further force or effect.

 

(iii) The Company shall notify the Purchaser
in writing of the anticipated date of the effectiveness of the Registration Statement (the “Effective Date”) at least
three (3) Business Days (as defined below) prior to the Effective Date, and the Purchaser shall remit the balance of the Initial
Purchase Price to the Company’s transfer agent (to be held in escrow pending the IPO Closing), by wire transfer of immediately available
funds or other means approved by the Company, on the date that is one (1) Business Day prior to the Effective Date, or such other
date as the Company and the Purchaser may agree upon in writing. As used herein, “Business Day” means any day, other
than a Saturday or a Sunday, that is neither a legal holiday nor a day on which banking institutions are generally authorized or required
by law or regulation to close in the City of New York, New York. If the IPO Closing has not occurred by the date that is seven (7) Business
Days after the date on which the Purchaser remitted the balance of its Initial Purchase Price to the Company’s transfer agent, then,
unless the Purchaser otherwise agrees in writing, the Company will promptly cause its transfer agent to return such amounts to the Purchaser.

 

(iv) In the event that the underwriters’
over-allotment option in connection with the IPO (the “Over-allotment Option”) is exercised, the Purchaser agrees to
purchase additional Private Placement Units as indicated on Schedule A at a price of $10.00 per unit. The Company shall
notify the Purchaser in writing of the anticipated date of each closing of the exercise of the Over-allotment Option, if any (each, an
 “Over-allotment Closing”) at least three (3) Business Days prior to such Over-allotment Closing, and the Purchaser
shall pay the purchase price for the Private Placement Units to be purchased in connection with such Over-allotment Closing by wire transfer
of immediately available funds or other means approved by the Company on that date that is one (1) Business Day prior to such Over-allotment
Closing (to be held in escrow pending such Over-allotment Closing), or such other date as the Company and the Purchaser may agree upon
in writing. If the Over-allotment Closing has not occurred by the date that is seven (7) Business Days after the date on which the
Purchaser remitted the purchase price for the Private Placement Units to be purchased in connection with such Over-allotment Closing,
then, unless the Purchaser otherwise agrees in writing, the Company will promptly cause its transfer agent to return such amounts to the
Purchaser.

 

     

     

    

 

(v) On the date of the IPO Closing, the Company
shall issue to the Purchaser the number of Private Placement Units set forth on Schedule A hereto. On the date of each
Over-allotment Closing, if any, the Company shall issue to Purchaser the number of Private Placement Units as set forth on Schedule
A.

 

	 	(b)	Delivery of Securities.

 

(i) The Company shall register the Purchaser
as the owner of the Subscribed Securities with the Company’s transfer agent by book entry on or prior to the date of the IPO Closing
(provided that prior to the Company’s appointment of a transfer agent it shall register the Purchaser as the owner of such securities
in the Company’s stock ledger upon issuance thereof).

 

(ii) Each register
and book entry for the Securities shall contain a notation, and each certificate (if any) evidencing the Securities shall be stamped or
otherwise imprinted with a legend, in substantially the following form:

 

“THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER
THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION, AND MAY NOT BE TRANSFERRED
IN VIOLATION OF SUCH ACT AND LAWS.

 

THE SALE, PLEDGE, HYPOTHECATION, OR TRANSFER OF THE SECURITIES REPRESENTED
HEREBY ARE SUBJECT TO THE TERMS AND CONDITIONS OF A CERTAIN SUBSCRIPTION AGREEMENT BY AND AMONG THE HOLDER AND THE OTHER PARTIES THERETO.
COPIES OF SUCH AGREEMENT MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY.”

 

(c) Registration Rights. On the Effective
Date, the Company shall enter into a Registration Rights Agreement (the “Registration Rights Agreement”) with the Sponsor,
the Subscribing Parties and certain other parties thereto, in substantially the form provided to the Purchaser prior to the date hereof.
The Registration Rights Agreement shall provide the Purchaser with registration rights with respect to the Subscribed Securities that
are no less favorable to the Purchaser than the registration rights of the Sponsor set forth therein.

 

2. Representations
and Warranties of the Purchaser. The Purchaser represents and warrants to the Company as follows, as of the date hereof:

 

(a) Organization and Power. The Purchaser
is duly organized, validly existing, and in good standing under the laws of the jurisdiction of its formation and has all requisite power
and authority to carry on its business as presently conducted and as proposed to be conducted.

 

(b) Authorization. The Purchaser has
full power and authority to enter into this Agreement. This Agreement, when executed and delivered by the Purchaser, will constitute the
valid and legally binding obligation of the Purchaser, enforceable against the Purchaser in accordance with its terms, except (i) as
limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any other laws of general application
affecting enforcement of creditors’ rights generally or (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies.

 

(c) Governmental Consents and Filings.
No consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal,
state or local governmental authority is required on the part of the Purchaser in connection with the consummation of the transactions
contemplated by this Agreement, except for filings pursuant to applicable securities laws, rules or regulations.

 

     

     

    

 

(d) Compliance with Other Instruments.
The execution, delivery and performance by the Purchaser of this Agreement and the consummation by the Purchaser of the transactions contemplated
by this Agreement will not result in any violation or default (i) under any provisions of its organizational documents, (ii) under
any instrument, judgment, order, writ or decree to which it is a party or by which it is bound, (iii) under any note, indenture or
mortgage to which it is a party or by which it is bound, (iv) under any lease, agreement, contract or purchase order to which it
is a party or by which it is bound or (v) under any provision of federal or state statute, rule or regulation applicable to
the Purchaser, in each case (other than clause (i)), which would have a material adverse effect on the Purchaser’s ability to consummate
the transactions contemplated by this Agreement.

 

(e) Purchase Entirely for Own Account.
This Agreement is made with the Purchaser in reliance upon the Purchaser’s representation to the Company, which by the Purchaser’s
execution of this Agreement, the Purchaser hereby confirms, that the Securities to be acquired by the Purchaser will be acquired for investment
for the Purchaser’s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof
in violation of any state or federal securities laws, and that the Purchaser has no present intention of selling, granting any participation
in, or otherwise distributing the same in violation of law. By executing this Agreement, the Purchaser further represents that the Purchaser
does not presently have any contract, undertaking, agreement or arrangement with any Person (other than the Company) to sell, transfer
or grant participations to such Person or to any third Person, with respect to any of the Securities. For purposes of this Agreement,
 “Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust,
an unincorporated organization, any other entity or any government or any department or agency thereof.

 

(f) Disclosure of Information. The Purchaser
has had an opportunity to discuss the Company’s business, management, financial affairs and the terms and conditions of the offering
of the Securities, as well as the terms of the Company’s proposed IPO, with the Company’s management.

 

(g) Restricted Securities. The Purchaser
understands that the offer and sale of the Securities to the Purchaser has not been and will not be registered under the Securities Act,
by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona
fide nature of the investment intent and the accuracy of the Purchaser’s representations as expressed herein. The Purchaser understands
that the Securities are “restricted securities” under applicable U.S. federal and state securities laws and that, pursuant
to these laws, the Purchaser must hold the Securities indefinitely unless they are registered with the SEC and qualified by state authorities,
or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that the Company has no
obligation to register or qualify the Securities except pursuant to the Registration Rights Agreement. The Purchaser further acknowledges
that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not
limited to, the time and manner of sale, the holding period for the Securities, and on requirements relating to the Company which are
outside of the Purchaser’s control, and which the Company is under no obligation and may not be able to satisfy. The Purchaser acknowledges
that the Company has confidentially submitted the Registration Statement for its proposed IPO. The Purchaser understands that the offering
of Securities and transactions contemplated hereunder are not and are not intended to be part of the IPO, and that the Purchaser will
not be able to rely on the protection of Section 11 of the Securities Act with respect to its purchase of Securities hereunder.

 

(h) No Public Market. The Purchaser understands
that no public market now exists for the Securities, and that the Company has not made any assurances that a public market will ever exist
for the Securities.

 

(i) High Degree of Risk. The Purchaser
understands that the purchase of the Subscribed Securities involves a high degree of risk which could cause the Purchaser to lose all
or part of its investment.

 

(j) Accredited Investor. The Purchaser
is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.

 

(k) No General Solicitation. Neither
the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners has either directly or indirectly, including,
through a broker or finder (i) to its knowledge, engaged in any general solicitation, or (ii) published any advertisement in
connection with the offer and sale of the Securities.

 

(l) Place of Investment Decision. The
Purchaser’s investment decision was made in the office or offices located at the address of the Purchaser set forth on the signature
page hereof.

 

     

     

    

 

(m) Adequacy of Financing. The Purchaser
will, when such funds are due hereunder, have sufficient funds to satisfy its obligations under this Agreement.

 

(o) No Other Representations and Warranties;
Non-Reliance. Except for the specific representations and warranties contained in this Section 3 and in any
certificate or agreement delivered pursuant hereto, none of the Purchaser nor any person acting on behalf of the Purchaser nor any of
the Purchaser’s affiliates (the “Purchaser Parties”) has made, makes or shall be deemed to make any other express
or implied representation or warranty with respect to the Purchaser and this offering, and the Purchaser Parties disclaim any such representation
or warranty. Except for the specific representations and warranties expressly made by the Company in Section 4 of
this Agreement and in any certificate or agreement delivered pursuant hereto, the Purchaser Parties specifically disclaim that they are
relying upon any other representations or warranties that may have been made by the Company, any person on behalf of the Company or any
of the Company’s affiliates (collectively, the “Company Parties”) with respect to the transactions contemplated
hereby.

 

3.  Representations,
Warranties and Covenants of the Company. The Company represents, warrants and covenants to the Purchaser as follows:

 

(a) Organization and Corporate Power.
The Company is formed and validly existing under the laws of the Cayman Islands and has all requisite corporate power and authority to
carry on its business as presently conducted and as proposed to be conducted.

 

(b) Authorization. All corporate action
required to be taken by the Company’s Board of Directors and stockholders in order to authorize the Company to enter into this Agreement,
and to issue the Subscribed Securities, has been taken on or prior to the date hereof. All action on the part of the stockholders, directors
and officers of the Company necessary for the execution and delivery of this Agreement, the performance of all obligations of the Company
under this Agreement, and the issuance and delivery of the Subscribed Securities has been taken on or prior to the date hereof. This Agreement,
when executed and delivered by the Company, shall constitute the valid and legally binding obligation of the Company, enforceable against
the Company in accordance with its terms except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium,
fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors’ rights generally
or (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies.

 

(c) Valid Issuance of Securities.

 

(i) The Subscribed Securities, when issued,
sold and delivered in accordance with the terms and for the consideration set forth in this Agreement, will be validly issued and fully
paid, as applicable, and free of all preemptive or similar rights, taxes, liens, encumbrances and charges with respect to the issue thereof
and restrictions on transfer other than restrictions on transfer specified under this Agreement, applicable state and federal securities
laws and liens or encumbrances created by or imposed by the Purchaser. Assuming the accuracy of the representations of the Purchaser in
this Agreement and subject to the filings described in Section 4(e) below, the Subscribed Securities will be issued
in compliance with all applicable federal and state securities laws, rules and regulations.

 

(ii) No “bad actor” disqualifying
event described in Rule 506(d)(1)(i)-(viii) of the Securities Act (a “Disqualification Event”) is applicable
to the Company or, to the Company’s knowledge, any Company Covered Person (as defined below), except for a Disqualification Event
as to which Rule 506(d)(2)(ii–iv) or (d)(3), is applicable. “Company Covered Person” means, with respect
to the Company as an “issuer” for purposes of Rule 506 promulgated under the Securities Act, any Person listed in the
first paragraph of Rule 506(d)(1).

 

(d) IPO.

 

(i) The Company has provided to the Purchaser,
and will at all times prior to the consummation of the IPO promptly provide to the Purchaser, copies of all correspondence sent by the
Company to, or received by the Company from, the SEC.

 

     

     

    

 

(ii) The offers and sales of securities in
the IPO will be made pursuant to an effective Registration Statement and otherwise in compliance with the Securities Act and the rules and
regulations promulgated thereunder and applicable state securities laws, rules and regulations.

 

(f) Governmental Consents and Filings.
Assuming the accuracy of the representations made by the Purchaser in this Agreement, no consent, approval, order or authorization of,
or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required
on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement, except for filings
pursuant to Regulation D of the Securities Act and applicable state securities laws, if any.

 

(g) Compliance with Other Instruments.
The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated by this Agreement will
not result in any violation or default (i) under any provisions of the certificate of incorporation, bylaws or other governing documents
of the Company, (ii) under any instrument, judgment, order, writ or decree to which the Company is a party or by which it is bound,
(iii) under any note, indenture or mortgage to which the Company is a party or by which it is bound, (iv) under any lease, agreement,
contract or purchase order to which the Company is a party or by which it is bound or (v) under any provision of federal or state
statute, rule or regulation applicable to the Company, in each case (other than clause (i)) which would have a material adverse effect
on the Company or its ability to consummate the transactions contemplated by this Agreement.

 

(h) Operations. As of the date hereof,
the Company has not conducted, and prior to the IPO Closing the Company will not conduct, any operations other than organizational activities
and activities in connection with offerings of the Securities.

 

(i) Foreign Corrupt Practices. Neither
the Company, nor any director, officer, agent, employee or other Person acting on behalf of the Company has, in the course of its actions
for, or on behalf of, the Company (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful
expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic government
official or employee from corporate funds; (iii) violated or is in violation of any provision of the U.S. Foreign Corrupt Practices
Act of 1977, as amended; or (iv) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment to
any foreign or domestic government official or employee.

 

(j) Compliance with Anti-Money Laundering
Laws. The operations of the Company are and have been conducted at all times in compliance with applicable financial recordkeeping
and reporting requirements and all other applicable U.S. and non-U.S. anti-money laundering laws and regulations, including, but not limited
to, those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the USA Patriot Act of 2001 and the applicable money
laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations
or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Anti-Money Laundering Laws”),
and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened.

 

(k) Absence of Litigation. There is no
action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization
or body pending or, to the knowledge of the Company, threatened against or affecting the Company or any of the Company’s officers
or directors, whether of a civil or criminal nature or otherwise, in their capacities as such.

 

(l) No General Solicitation.
Neither the Company, nor any of its officers, managers, employees, agents or members has either directly or indirectly, including, through
a broker or finder (i) engaged in any general solicitation or (ii) published any advertisement in connection with the offer
and sale of the Subscribed Securities.

 

(m) Non-Public Information. The Company
represents and warrants that none of the information conveyed to the Purchaser in connection with the transactions contemplated by this
Agreement will constitute material non-public information of the Company upon the effectiveness of the Registration Statement.

 

     

     

    

 

(n) No Other Representations and Warranties;
Non-Reliance. Except for the specific representations and warranties contained in this Section 3 and in any
certificate or agreement delivered pursuant hereto, none of the Company Parties has made, makes or shall be deemed to make any other express
or implied representation or warranty with respect to the Company or the offering of Securities hereunder, and the Company Parties disclaim
any such representation or warranty. Except for the specific representations and warranties expressly made by the Purchaser in Section 2 of
this Agreement and in any certificate or agreement delivered pursuant hereto, the Company Parties specifically disclaim that they are
relying upon any other representations or warranties that may have been made by the Purchaser Parties.

 

4. Additional Agreements and Acknowledgements
of the Purchaser.

 

(a) Transfer Restrictions. The Purchaser
agrees that it shall not Transfer (as defined below) (i) any Founder Shares until the earlier of (A) six months after the closing
of the Business Combination (the “Business Combination Closing”) and (B) the date following the Business Combination
Closing on which the Company completes a liquidation, merger, stock exchange or other similar transaction that results in all of the Company’s
stockholders having the right to exchange their Ordinary Shares for cash, securities or other property (such period, the “Lock-up
Period”) or (ii) any Private Placement Units (or any Ordinary Shares issuable upon exercise of the Private Placement Units)
until 30 days after the Business Combination Closing. Notwithstanding the first sentence hereinabove, Transfers of the Securities are
permitted (i) to any other person or entity that holds Ordinary Shares prior to the consummation of the IPO; (ii) to the Company’s
officers, directors or employees; (iii) in the case of an entity, as a distribution to its partners, stockholders or members upon
liquidation; (iv) in the case of an individual, by gift to a member of the individual’s immediate family, to a trust, the beneficiary
of which is a member of the individual’s immediate family, for estate planning purposes; (v) in the case of an individual,
by virtue of laws of descent and distribution upon death of the individual; (vi) in the case of an individual, pursuant to a qualified
domestic relations order; (vii) by pledges to secure obligations incurred in connection with purchases of the Company’s securities;
(viii) by private sales or transfers made in connection with the consummation of a Business Combination at prices no greater than
the price at which the applicable Securities were originally purchased; (ix) in the event of the Company’s liquidation, bankruptcy
or dissolution prior to the completion of a Business Combination; (x) to the Purchaser’s affiliates, to any investment fund
or other entity controlled or managed by the Purchaser, or to any investment manager or investment advisor of the Purchaser or an affiliate
of any such investment manager or investment advisor or to any investment fund or other entity controlled or managed by such persons;
(xi) to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses (i) through
(x) above; and (xii) pursuant to the provisions of Section 2 of this Agreement (each of the foregoing,
a “Permitted Transferee”); provided, however, that in the case of clauses (i) through (xi), these permitted transferees
must enter into a written agreement agreeing to be bound by the terms of this Agreement, including the forfeiture provisions of Section 2 and
these transfer restrictions. As used in this Agreement, “Transfer” shall mean the (x) sale of, offer to sell,
contract or agreement to sell, hypothecation, pledge, grant of any option to purchase or otherwise dispose of or agreement to dispose
of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease of a
call equivalent position (within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), and the rules and regulations of the SEC promulgated thereunder) with respect to, any of the Securities; (y) entry
into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any
of the Securities, whether any such transaction is to be settled by delivery of such Securities, in cash or otherwise, or (z) public
announcement of any intention to effect any transaction specified in clause (x) or (y); provided further, that this Section 5(a) shall
not prohibit the Purchaser from effecting a Short Sale (as defined below) with securities that do not constitute “Securities”
under this Agreement.

 

(b) Trust Account.

 

(i) The Purchaser hereby acknowledges that
it is aware that the Company will establish the Trust Account for the benefit of its public stockholders upon the IPO Closing. The Purchaser
hereby agrees that it has no right, title, interest or claim of any kind in or to any monies held in the Trust Account, or any other asset
of the Company as a result of any liquidation of the Company, except for redemption and liquidation rights, if any, the Purchaser may
have in respect of any Public Shares held by it, and any securities of the Company acquired by Purchaser other than as a result of this
Agreement.

 

     

     

    

 

(ii)  The Purchaser hereby agrees that it
shall have no right of set-off or any right, title, interest or claim of any kind (“Claim”) to, or to any monies in,
the Trust Account, and hereby irrevocably waives any Claim to, or to any monies in, the Trust Account that it may have now or in the future,
except for redemption and liquidation rights, if any, the Purchaser may have in respect of any Public Shares held by it, and any securities
of the Company acquired by Purchaser other than as a result of this Agreement. In the event the Purchaser has any Claim against the Company
under this Agreement, the Purchaser shall pursue such Claim solely against the Company and its assets outside the Trust Account and not
against the property or any monies in the Trust Account, except for redemption and liquidation rights, if any, the Purchaser may have
in respect of any Public Shares held by it.

 

(c)  No Short Sales. The Purchaser
hereby agrees that neither it, nor any person or entity acting on its behalf, will engage in any Short Sales with respect to securities
of the Company prior to the closing of the Business Combination. For purposes of this Section 5.1(c), “Short Sales” shall
include, without limitation, all “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange
Act, and all types of direct and indirect stock pledges (other than pledges in the ordinary course of business as part of prime brokerage
arrangements), forward sale contracts, options, puts, calls, swaps and similar arrangements (including on a total return basis).

 

(d) Use of Purchaser’s Name. Neither
the Company nor the Sponsor will, without the written consent of the Purchaser in each instance, use in advertising, publicity or otherwise
the name of the Purchaser or any of its affiliates, or any director, officer or employee of the Purchaser, nor any trade name, trademark,
trade device, service mark, symbol or any abbreviation, contraction or simulation thereof owned by the Purchaser or its affiliates or
any information relating to the business or operations of the Purchaser or its affiliates (including, for the avoidance of doubt, any
investment vehicles, funds or accounts managed thereby). Notwithstanding the foregoing, the Company may disclose (i) Purchaser’s
name and information concerning the Purchaser (A) to the extent required by law, regulation or regulatory request, including in the
Registration Statement or (B) to the Company’s lawyers, independent accountants and to other advisors and service providers
who reasonably require Purchaser’s information in connection with the provision of services to the Company, are advised of the confidential
nature of such information and are obligated to keep such information confidential, and (ii) Purchaser’s name and the terms
of this Agreement to the other Subscribing Parties. The Company and the Sponsor agree to provide to the Purchaser for Purchaser’s
review any disclosure in any registration statement, proxy statement or other document in advance of the submission, filing or disclosure
of such document in connection with the transactions contemplated by this Agreement with respect to the Purchaser or any of its affiliates,
and will not make any such submission, filing or disclosure without including any revisions reasonably requested in writing by the Purchaser
or to the extent the Purchaser has a good faith objection to such submission, filing or disclosure.

 

5.
General Provisions.

 

(a) Notices. All notices and other communications
given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given upon the earlier of actual receipt,
or (i) personal delivery to the party to be notified, (ii) when sent, if sent by electronic mail or facsimile (if any) during
normal business hours of the recipient, and if not sent during normal business hours, then on the recipient’s next Business Day,
(iii) five (5) Business Days after having been sent by registered or certified mail, return receipt requested, postage prepaid,
or (iv) one (1) Business Day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next
Business Day delivery, with written verification of receipt. All communications sent to the Company shall be sent to: Lakeshore Acquisition
II Corp., [                           ],
Attention: [                           ],
Email:[                           ],
with a copy to Loeb & Loeb LLP, 345 Park Ave, New York, New York 10154, Attention: Giovanni Caruso, Email: gcaruso@loeb.com.

 

All communications to the Purchaser shall be sent
to the Purchaser’s address as set forth on the signature page hereto, or to such email address, facsimile number (if any) or
address as subsequently modified by written notice given in accordance with this Section 6(a).

 

     

     

    

 

(b) No Finder’s Fees. Each party
represents that it neither is nor will be obligated for any finder’s fee or commission in connection with this transaction. The
Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of
a finder’s or broker’s fee arising out of this transaction (and the costs and expenses of defending against such liability
or asserted liability) for which the Purchaser or any of its officers, employees or representatives are responsible. The Company agrees
to indemnify and hold harmless the Purchaser from any liability for any commission or compensation in the nature of a finder’s or
broker’s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability)
for which the Company or any of its officers, employees or representatives is responsible.

 

(c) Survival of Representations and Warranties.
All of the representations and warranties contained herein shall survive the consummation of the transactions contemplated by this Agreement.

 

(d) Entire Agreement. This Agreement,
together with any other documents, instruments and writings that are delivered pursuant hereto or referenced herein, constitutes the entire
agreement and understanding of the parties hereto in respect of its subject matter and supersedes all prior understandings, agreements,
or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof
or the transactions contemplated hereby.

 

(e) Successors. All of the terms, agreements,
covenants, representations, warranties, and conditions of this Agreement are binding upon, and inure to the benefit of and are enforceable
by, the parties hereto and their respective successors. Nothing in this Agreement, express or implied, is intended to confer upon any
party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations or liabilities under
or by reason of this Agreement, except as expressly provided in this Agreement.

 

(f) Assignments. Except as otherwise
specifically provided herein, no party hereto may assign either this Agreement or any of its rights, interests, or obligations hereunder
without the prior written approval of the other party.

 

(g) Counterparts. This Agreement may
be executed in two or more counterparts, each of which will be deemed an original but all of which together will constitute one and the
same instrument.

 

(h) Headings. The section headings contained
in this Agreement are inserted for convenience only and will not affect in any way the meaning or interpretation of this Agreement.

 

(i) Governing Law. This Agreement, the
entire relationship of the parties hereto, and any litigation between the parties (whether grounded in contract, tort, statute, law or
equity) shall be governed by, construed in accordance with, and interpreted pursuant to the laws of the State of New York, without giving
effect to its choice of laws principles.

 

(j) Jurisdiction. The parties hereby
irrevocably and unconditionally (i) submit to the jurisdiction of the state courts of New York and the United States District Court
for the Southern District of New York for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement,
(ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in state courts
of New York or the United States District Court for the Southern District of New York, and (iii) waive, and agree not to assert,
by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the
jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding
is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject
matter hereof may not be enforced in or by such court.

 

(k) WAIVER OF JURY TRIAL. THE PARTIES
HERETO HEREBY WAIVE ANY RIGHT TO A JURY TRIAL IN CONNECTION WITH ANY LITIGATION PURSUANT TO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED
HEREBY.

 

(l) Amendments. This Agreement may not
be amended, modified or waived as to any particular provision, except with the prior written consent of the Company and the Purchaser.

 

     

     

    

 

(m) Severability. The provisions of this
Agreement will be deemed severable and the invalidity or unenforceability of any provision will not affect the validity or enforceability
of the other provisions hereof; provided that if any provision of this Agreement, as applied to any party hereto or to any circumstance,
is adjudged by a governmental authority, arbitrator, or mediator not to be enforceable in accordance with its terms, the parties hereto
agree that the governmental authority, arbitrator, or mediator making such determination will have the power to modify the provision in
a manner consistent with its objectives such that it is enforceable, and/or to delete specific words or phrases, and in its reduced form,
such provision will then be enforceable and will be enforced.

 

(n)  Expenses. Each of the Company
and the Purchaser will bear its own costs and expenses incurred in connection with the preparation, execution and performance of this
Agreement and the consummation of the transactions contemplated hereby, including all fees and expenses of agents, representatives, financial
advisors, legal counsel and accountants. The Company shall be responsible for the fees of its transfer agent, stamp taxes and all of The
Depository Trust Company’s fees associated with the issuance of the Securities and the securities issuable upon conversion or exercise
of the Securities.

 

(o) Construction. The parties hereto
have participated jointly in the negotiation and drafting of this Agreement. If an ambiguity or question of intent or interpretation arises,
this Agreement will be construed as if drafted jointly by the parties hereto and no presumption or burden of proof will arise favoring
or disfavoring any party hereto because of the authorship of any provision of this Agreement. Any reference to any federal, state, local,
or foreign law will be deemed also to refer to law as amended and all rules and regulations promulgated thereunder, unless the context
requires otherwise. The words “include,” “includes,” and “including” will be deemed to be followed
by “without limitation.” Pronouns in masculine, feminine, and neuter genders will be construed to include any other gender,
and words in the singular form will be construed to include the plural and vice versa, unless the context otherwise requires. The words
 “this Agreement,” “herein,” “hereof,” “hereby,” “hereunder,” and words of
similar import refer to this Agreement as a whole and not to any particular subdivision unless expressly so limited. The parties hereto
intend that each representation, warranty, and covenant contained herein will have independent significance. If any party hereto has breached
any representation, warranty, or covenant contained herein in any respect, the fact that there exists another representation, warranty
or covenant relating to the same subject matter (regardless of the relative levels of specificity) which such party hereto has not breached
will not detract from or mitigate the fact that such party hereto is in breach of the first representation, warranty, or covenant.

 

(p) Waiver. No waiver by any party hereto
of any default, misrepresentation, or breach of warranty or covenant hereunder, whether intentional or not, may be deemed to extend to
any prior or subsequent default, misrepresentation, or breach of warranty or covenant hereunder or affect in any way any rights arising
because of any prior or subsequent occurrence.

 

(q) Specific Performance. Each party
hereto agrees that irreparable damage may occur in the event any provision of this Agreement was not performed by the other party hereto
in accordance with the terms hereof and that the such party shall be entitled to specific performance of the terms hereof, in addition
to any other remedy at law or equity.

 

(r) Confidentiality. Except as may be
required by law, regulation or applicable stock exchange listing requirements (but subject in any case to the provisions of Section 5(d) hereof),
unless and until the transactions contemplated hereby and the terms hereof are publicly announced or otherwise publicly disclosed by the
Company, the parties hereto shall keep confidential and shall not publicly disclose the existence or terms of this Agreement. Notwithstanding
the foregoing, the Purchaser shall be permitted to disclose any information to its affiliates and its and their respective directors,
officers, employees, advisors, director or indirect owners, agents and representatives, in each case so long as such person or entity
has been advised of the confidentiality obligations hereunder; provided that the Purchaser shall be liable for any breach of such confidentiality
obligations by any such person or entity.

 

[Signature page follows]

 

     

     

    

 

IN
WITNESS WHEREOF, the undersigned have executed this Agreement to be effective as of the date first set forth above.

 

COMPANY:

 

LAKESHORE ACQUISITION II CORP.

 

	By:	 	 
	Name:	 
	Title:	 

 

SPONSOR:

 

REDONE INVESTMENT LIMITED

 

	By:	 	 
	Name:	 
	Title:	 

 

PURCHASER:

 

	By:	 	 
	Name:	 
	Title:	 

 

Purchaser’s
Address for Notices:

 

Schedule A

 

	 	 	Number of 

Subscribed 

Securities	 	 	Initial Purchase 

Price	 
	Founder Shares	 	 	 	 	 	$	 	 
	Private Placement Units	 	 	 	 	 	$	 	 

 

* In the event that the Over-allotment Option is exercised, the Purchaser
agrees to purchase up to an additional $[_] of Private Placement Units at a price of $10.00 per units, in the same proportion as the amount
of the over-allotment option that is exercised.Exhibit
10.1

 

THE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES
LAWS OF ANY STATE OR ANY OTHER JURISDICTION. THERE ARE FURTHER RESTRICTIONS ON THE TRANSFERABILITY OF THE SECURITIES DESCRIBED HEREIN.
THE PURCHASE OF THE SECURITIES INVOLVES A HIGH DEGREE OF RISK AND SHOULD BE CONSIDERED ONLY BY PERSONS WHO CAN BEAR THE RISK OF THE LOSS
OF THEIR ENTIRE INVESTMENT.

 

STOCK
PURCHASE AGREEMENT

 

THIS
STOCK PURCHASE AGREEMENT (this “Agreement”) is entered into on __ day of January 2022 (the “Closing Date”),
by and between the undersigned purchaser (the “Investor”) and theMaven, Inc., a Delaware corporation (“Maven”
or the “Company”).

 

RECITALS

 

WHEREAS,
in connection with that certain Registration Rights Agreement(s) between Investor and the Company (collectively, the “Registration
Rights Agreement”), which was made in connection with certain Securities Purchase Agreement(s) by and between Investor and
the Company (collectively, the “Securities Purchase Agreement”), the Investor is entitled to receive from the Company,
in the event of certain defaults, liquidated damages (the “Liquidated Damages”) in connection with the failure of
the Company to comply with certain timeframes set forth in the Registration Rights Agreement. The execution date(s) of the Registration
the Rights Agreement and Securities Purchase Agreement, as well as the cash value of the Liquidated Damages due to Investor as of the
date of this Agreement, are set forth in Exhibit “A” attached to this Agreement (“Exhibit A”);
and

 

WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act and Rule 506 of
Regulation D promulgated thereunder, the Company desires to issue to the Investor, and the Investor desires to receive from the Company,
pursuant to the terms set forth herein, the number of shares set forth on Exhibit A (the “Shares”) of the Company’s
restricted common stock, par value $0.01 per share (the “Common Stock”), in lieu of receiving the Liquidated Damages
in cash, as soon as reasonably practicable following the date of execution of this Agreement.

 

NOW,
THEREFORE, IN CONSIDERATION of the foregoing premises and the mutual covenants contained in this Agreement, and for other good and valuable
consideration, the adequacy and sufficiency of which are hereby acknowledged, the Company and the Investor agree as follows:

 

ARTICLE
I

PURCHASE AND SALE

 

Section
1.1 Issuance. The Company hereby issues to the Investor the Shares, at a per share value equal to the amount set forth on
Exhibit A, in exchange for the cancellation, waiver and release of the Company’s obligation to pay the Investor the Liquidated
Damages, set forth on Exhibit A to this Agreement. The parties hereto agree that the receipt and acceptance of the Shares are adequate
consideration for the resolution of all claims for liquidated damages. The Issuance Price has been determined to be equal to the volume-weighted
average price of the Company’s common stock at the close of trading on the sixty (60) trading days ending on January 14, 2022.

 

Section
1.2 Closing Conditions. The obligations of the Company hereunder are subject to the following conditions being met: (a) the
accuracy in all material respects on the Effective Date of the representations and warranties of the Investor contained herein; and (b)
all obligations, covenants, and agreements of the Investor required to be performed at or prior to the date hereof shall have been performed.

 

Section
1.3 Book-Entry Notation. The Company shall instruct the Company’s transfer agent to record the issuance of the Shares
to the Investor via book-entry notation, as soon as reasonably practicable following the date hereof.

 

    	 

    	 

    

 

ARTICLE
II

REPRESENTATIONS AND WARRANTIES

 

Section
2.1 Representations and Warranties of Investor. To induce the Company to issue the Shares to the Investor, the Investor hereby
represents and warrants as of the date hereof as follows:

 

(a)
Organization; Authority. The Investor is either an individual, or an entity duly incorporated or formed, validly existing, and
in good standing under the laws of the jurisdiction of its incorporation or formation, with full right, corporate, partnership, limited
liability company, or similar power and authority to enter into and to consummate the transactions contemplated herby and otherwise to
carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and performance by Investor of the transactions
contemplated hereby have been duly authorized by all necessary corporate, partnership, limited liability company, or similar action,
as applicable, on the part of the Investor, and, when executed, will constitute the valid and legally binding obligation of the Investor.
The Investor has not been formed for the specific purpose of acquiring the Shares. If Investor is an entity, the Persons (as defined
below) executing the Agreement on behalf of the Investor represent that they are duly authorized to execute all such documents on behalf
of the entity. As used in this Agreement, “Person” means an individual or corporation, partnership, trust, incorporated or
unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof),
or other entity of any kind.

 

(b)
Restricted Securities; Own Account. The Investor understands that the Shares are “restricted securities” and have
not been registered under the Securities Act or any applicable state securities law. The Investor is acquiring the Shares as principal
for its own account and not with a view to or for distributing or reselling such Shares or any part thereof in violation of the Securities
Act or any applicable state securities law, has no present intention of distributing any of such Shares in violation of the Securities
Act or any applicable state securities law, and has no direct or indirect arrangement or understandings with any other persons to distribute
or regarding the distribution of such Shares in violation of the Securities Act or any applicable state securities. The Investor is acquiring
the Shares hereunder in the ordinary course of its business.

 

(c)
Accredited Investor. At the time the Investor was offered the Shares to be issued pursuant to this Agreement, it was, and as of
the date hereof it is, an “accredited investor” as defined in Rule 501(a) of Regulation D under the Securities Act.

 

(d)
Experience of the Investor. The Investor, either alone or together with its representatives, has such knowledge, sophistication,
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Shares, and has so evaluated the merits and risks of such investment. The Investor is able to bear the economic risk of an investment
in the Shares and, at the present time, is able to afford a complete loss of such investment.

 

(e)
Access to Information. The Investor acknowledges that (i) he/she/it has reviewed and understands the Company’s Annual Report
on Form 10-K, for the year ending December 31, 2020, and each of the Company’s Quarterly Reports on Form 10-Q, for the periods
ending March 31, 2021, June 30, 2021 and September 30, 2021, all filed with the United States Securities and Exchange Commission on August
16, 2021, and that access to such information about the Company and its financial condition, results of operations, business, properties,
management, and prospects is sufficient to enable him/her/it to evaluate his/her/its investment; and (ii) has been afforded the opportunity
to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision with respect to the investment.

 

(f)
Non-Reliance. The Investor represents that he/she/it is not relying on (and will not at any time rely on) any communication (written
or oral) of the Company, as investment advice or as a recommendation to purchase the Shares. The Investor confirms that the Company has
not (i) given any guarantee or representation as to the potential success, return, effect, or benefit (either legal, regulatory, tax,
financial, accounting or otherwise) of an investment in the Shares or (ii) made any representation to the Investor regarding the legality
of an investment in the Shares under applicable legal investment or similar laws or regulations. In deciding to purchase the Shares,
the Investor is not relying on the advice or recommendations of the Company and the Investor has made his/her/its own independent decision
that the investment in the Shares is suitable and appropriate for the Investor.

 

    	2

    	 

    

 

(g)
Speculative Securities. The Investor acknowledges the Shares are highly speculative securities, that involve a high degree of
risk, and should only be purchased by Persons who can afford the loss of their entire investment. The Investor acknowledges that he/she/it
has carefully reviewed and understands the risks of, and other considerations relating to, a purchase of the Shares.

 

(h)
No “Bad Actor” Disqualification. Neither (i) the Investor nor (ii) if applicable, any entity that controls the Investor
or is under the control of, or under common control with, such Person, is subject to any Disqualification Event (as such term is defined
under the Securities Act), except for Disqualification Events covered by Rule 506(d)(ii) or (iii) or (d)(3) of the Securities Act and
disclosed in writing in reasonable detail to the Company. The Investor has exercised reasonable care to determine the accuracy of the
representation made by the Investor in this paragraph, and agrees to notify the Company if the Investor becomes aware of any fact that
made the representation given by the Investor hereunder inaccurate.

 

(i)
Tax Advice. The Investor has obtained such additional tax and other advice that it has deemed necessary in connection with this
issuance, and the Investor understands it will be responsible for its own tax liability that may arise as a result of this investment
or the transactions contemplated by this Agreement.

 

(j)
No General Solicitation. The Investor acknowledges that neither the Company nor any other Person offered to issue the Shares to
him/her/it by means of any form of general solicitation or advertising.

 

(k)
Reliance on Exemptions. The Investor understand that the Shares being offered and issued to him/her/it in reliance on specific
exemptions from the registration requirements of federal and state securities laws and that the Company is relying in part upon the truth
and accuracy of, and the Investor’s compliance with, the representations, warranties, agreements, acknowledgements, and understandings
of the Investor set forth herein in order to determine the availability of such exemptions and the eligibility of the Investor to acquire
the Shares.

 

ARTICLE
III

OTHER AGREEMENTS OF THE PARTIES

 

Section
3.1 Transfer Restrictions. Notwithstanding any other provision of this Agreement, the Investor covenants that he/she/it will
not sell, assign, pledge, give, transfer or otherwise dispose of the Shares or any interest therein, or make any offer or attempt to
do any of the foregoing, except pursuant to an effective registration statement under, and in compliance with the requirements of, the
Securities Act, or pursuant to an available exemption from, or in a transaction not subject to, the registration requirements of the
Securities Act, and in compliance with any applicable state and federal securities laws. Consequently, the Investor understands that
he/she/it must bear the economic risks of the investment in the Shares for an indefinite period of time. In connection with any transfer
of Shares other than (i) pursuant to an effective registration statement, (ii) to the Company or to an affiliate of the Investor, or
(iii) pursuant to Rule 144 of the Securities Act (provided, that, when Rule 144 become available, Investor provides the Company
with reasonable assurances (in the form of seller and, if applicable, broker representation letters), that the securities may be sold
pursuant to such rule), the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the
transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the
Company, to the effect that such transfer does not require registration of such transferred Shares under the Securities Act or applicable
state securities law. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement
and shall have the rights and obligations of Investor under this Agreement with respect to such transferred Shares. The Company and its
affiliates shall not be required to give effect to any purported transfer of the Shares except upon compliance with the foregoing restrictions.

    	3

    	 

    

 

 

Section
3.2 Legends. Any certificates or book-entry notations shall bear a legend as required by the “blue sky” laws of
any state and a restrictive legend in substantially the following form, until such time as they are not required under this Agreement
and applicable securities laws:

 

THE
OFFER AND SALE OF THESE SECURITIES HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
OR ANY APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, ASSIGNED, OR OTHERWISE DISPOSED
OF (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OR (B) AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN EACH CASE IN ACCORDANCE WITH APPLICABLE
STATE SECURITIES LAWS OR BLUE SKY LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY AND ITS TRANSFER
AGENT OR (II) UNLESS SOLD PURSUANT TO RULE 144 UNDER THE SECURITIES ACT.

 

Section
3.3 Registration Rights. The Company hereby agrees that it shall undertake to prepare and file with the Securities and Exchange
Commission as soon as reasonably practicable, but in no event later than one year following the Closing Date, a Registration Statement
covering the resale of all of the Shares issued hereunder that are not then registered on an existing and effective Registration Statement
for an offering to be made on a continuous basis pursuant to Rule 415. The parties hereto hereby acknowledge that the Company is currently
engaged in a proposed firm commitment underwritten offering (“Primary Offering”) of its Common Stock and that the
Company’s ability to immediately file a Registration Statement covering the resale of the Shares issued hereunder will be affected
by the Primary Offering, among other items.

 

Section
3.4 Further Assurances. The Company reserves the right to request, and the Investor agrees to deliver to the Company, any
further documents, certifications, or information from the Investor, in the Company’s sole discretion, that the Company may deem
necessary or advisable in order to carry out or effect one or more of the obligations or restrictions imposed in connection with applicable
securities laws and the aforementioned the Investor requirements.

 

ARTICLE
IV

MISCELLANEOUS

 

Section
4.1 Fees and Expenses. Each party shall pay the fees and expenses of its advisers, counsel, accountants, and other experts,
if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery, and performance
of this Agreement. The Company shall pay all transfer agent fees (including, without limitation, any fees required for same-day processing
of any instruction letter delivered by the Company), stamp taxes, and other taxes and duties levied in connection with the delivery of
the Shares to the Investor.

 

Section
4.2 Limited Release. In consideration of the covenants, agreements, and undertakings of the parties in this Agreement, effective
upon the issuance by the Company of the Shares to the Investor in lieu of receiving the Liquidated Damages, the Investor, on behalf of
himself/herself/itself and his/her/its respective present and former parent, subsidiaries, affiliates, officers, directors, shareholders,
managers, members, successors and assignees (collectively, “Releasors”) hereby releases, waives, and forever discharges
the Company and its respective present and former, direct and indirect, subsidiaries, affiliates, employees, officers, directors, stockholders,
agents, representatives, permitted successors and assigns (collectively, “Releasees”) from any and all actions, causes
of action, suits, losses, liabilities, rights, debts, sums of money, obligations, costs, expenses, obligations, damages, judgements,
claims and demands, whether known or unknown, in law or equity, for which such Releasor had through the date of this Agreement, arising
out of or relating to the Liquidated Damages.

 

Section
4.3 Entire Agreement. This Agreement constitutes the entire agreement between the parties hereto with regard to the subject
matter hereof.

 

Section
4.4 Notices. Any notice required to be given under this Agreement shall be in writing and shall be deemed effective upon personal
delivery or upon deposit in the U.S. mail, registered or certified, postage prepaid and properly addressed to the party entitled to such
notice at the address indicated below such party’s signature line in this Agreement or at such other address as such party may
designate by ten (10) days advance written notice under this paragraph to all other parties to this Agreement.

 

    	4

    	 

    

 

Section
4.5 Amendments; Waivers. Any provision of this Agreement may be amended, waived, or modified upon the written consent of the
Company and Investor.

 

Section
4.6 Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and permitted assigns.

 

Section
4.7 Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York,
without regard to the principles of conflicts of law thereof. With respect to any suit, action or proceeding relating this Agreement,
the parties irrevocably submit to the jurisdiction of the federal or state courts located in the City of New York, Borough of Manhattan,
which submission shall be exclusive unless none of such courts has lawful jurisdiction over such proceedings.

 

Section
4.8 Survival; Indemnification. The representations, warranties, and covenants contained herein shall survive for a period
of two (2) years after the delivery of the Shares. The Investor agrees to indemnify and hold harmless the Company and its managers, officers,
directors, employees, agents, and affiliates from and against all damages, losses, costs, and expenses (including reasonable attorneys’
fees) that they may incur by reason of the failure of the Investor to fulfill any of the terms or conditions of this Agreement, or by
reason of any breach of the representations and warranties made by the Investor herein, or in any document provided by Investor to the
Company.

 

Section
4.9 Counterparts. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party
executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature
page were an original thereof.

 

Section
4.10 Severability. If any term, provision, covenant, or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void, or unenforceable, the remainder of the terms, provisions, covenants, and restrictions set forth herein
shall remain in full force and effect and shall in no way be affected, impaired, or invalidated, and the parties hereto shall use their
commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that
contemplated by such term, provision, covenant, or restriction.

 

Section
4.11 Construction. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity
to revise this Agreement and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of this Agreement or any amendments thereto. In addition, each and every
reference to shares of Common Stock in this Agreement shall be subject to adjustment for reverse and forward stock splits, stock dividends,
stock combinations, and other similar transactions of the Common Stock that occur after the date of this Agreement.

 

(Signature
Page to Follow)

 

    	5

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Stock Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

	THEMAVEN, INC. 	 	Address
    for Notice:
	 	 	 	200
Vesey Street, 24th Floor
	 	 	 	New York, NY 10281
	By:	              	 	Email:
    legal@thearenagroup.net
	Name:	 	 	 
	Title:	 	 	 

 

With
a copy to (which shall not constitute notice):

 

Baker
& Hostetler LLP

Attention:
Jeffrey P. Berg

11601
Wilshire Boulevard, Suite 1400,

Los
Angeles, California 90025-0509

 

	Name
    of Investor: ______________________
	Signature of Authorized Signatory of Investor: ______________________________________
	Name of Authorized Signatory:__________________________________________________
	Title of Authorized Signatory: ___________________________________________________
	Email Address of Authorized Signatory: ___________________________________________
	Facsimile
    Number of Authorized Signatory: _________________________________________

 

Address
for Notice to Investor:

________________

________________

________________

 

Investor’s
SSN or Tax I.D. Number: ____________________________

 

    	6

    	 

    

 

EXHIBIT
A

 

Liquidated
Damages Election Notice

 

	Execution
    Date of Registration Rights Agreement: 	 	_________
    ___, 20__
	Execution
    Date of Securities Purchase Agreement:	 	_________
    ___, 20__
	Series
    of Preferred Stock Offering (if applicable):	 	Series
    ___
	Original
    “Subscription Amount” as defined in the Securities Purchase Agreement:	 	 $
    ___________
	Liquidated
    Damages due to the Investor as of date of this Agreement (including initial amount due and any accrued but unpaid interest, not to
    exceed any “maximum amount” set forth in the Registration Rights Agreement):	 	$
    __________ (initial amount due)

    +
    $ __________ (interest to date)

     

    =
    $___________ (Aggregate Liquidated Damages)

	Price
    per share of the Shares issued to the Investor under this Agreement:	 	$0.63
    per share
	Number
    of Shares to be acquired by the Investor pursuant to this Agreement:	 	________
    Shares

 

    	7

    	 

    

 

THEMAVEN,
INC.

200
Vesey Street, 24th Floor

New
York, NY 10281

 

	 	January
    21, 2022

 

Dear
Investor,

 

I
am writing on behalf of theMaven, Inc. (“Maven” or the “Company”) relating to the
Stock Purchase Agreement (the “SPA”) recently sent to you in connection with the cancellation of the Company’s
obligation to pay to you Liquidated Damages in return for that number of Shares set forth in Exhibit A of the SPA (the “Transactions”).
Any defined terms used in this Letter that are not defined herein will have the same meaning given it in the SPA.

 

In
connection with the Transactions, and as further consideration for your entry into the SPA, the Company hereby represents and warrants
to you as follows:

 

(a)
All corporate action required to be taken by the Company’s Board of Directors to authorize the Company to enter into the SPA, and
to issue the Shares, has been taken or will be taken prior to the Closing and the delivery of the Shares.

 

(b)
The SPA, when executed and delivered by the Company, shall constitute valid and legally binding obligations of the Company, enforceable
against the Company in accordance with their respective terms except (i) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors’
rights generally, and (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable
remedies.

 

(c)
The Shares, when issued, sold and delivered in accordance with the terms and for the consideration set forth in the SPA and this Agreement,
will be validly issued, fully paid and nonassessable.

 

The
Company agrees to indemnify and hold harmless you and your managers, officers, directors, employees, agents, and affiliates from and
against all damages, losses, costs, and expenses (including reasonable attorneys’ fees) that you may incur by reason of any breach
of the representations and warranties made the Company herein.

 

We
appreciate your attention to the offer being made in the SPA.

 

	 	Very
    truly yours,
	 	 
	 	Douglas
B. Smith
	 	Chief
Financial Officer 

 

    	8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}]]